Respiratory Viral Infections in Hematopoietic Stem Cell and Solid Organ Transplant Recipients

ABSTRACT

Respiratory viral infections (RVIs) are common causes of mild illness in immunocompetent children and adults with rare occurrences of significant morbidity or mortality. Complications are more common in the very young, very old, and those with underlying lung diseases. However, RVIs are increasingly recognized as a cause of morbidity and mortality in recipients of hematopoietic stem cell transplants (HSCT) and solid organ transplants (SOTs). Diagnostic techniques for respiratory syncytial virus (RSV), parainfluenza, influenza, and adenovirus have been clinically available for decades, and these infections are known to cause serious disease in transplant recipients. Modern molecular technology has now made it possible to detect other RVIs including human metapneumovirus, coronavirus, and bocavirus, and the role of these viruses in causing serious disease in transplant recipients is still being worked out. This article reviews the current information regarding epidemiology, pathogenesis, clinical presentation, diagnosis, and treatment of these infections, as well as the aspects of clinical significance of RVIs unique to HSCT or SOT.

KEYWORDS

Respiratory viral infection (RVI) - transplant - community acquired respiratory virus (CARV) - respiratory syncytial virus - influenza - parainfluenza

REFERENCES

• 1 Hall C B, Weinberg G A, Iwane M K et al.. The burden of respiratory syncytial virus infection in young children.  N Engl J Med. 2009;  360 (6) 588-598
• 2 Falsey A R, Hennessey P A, Formica M A, Cox C, Walsh E E. Respiratory syncytial virus infection in elderly and high-risk adults.  N Engl J Med. 2005;  352 (17) 1749-1759
• 3 Boyce T G, Mellen B G, Mitchel Jr E F, Wright P F, Griffin M R. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid.  J Pediatr. 2000;  137 (6) 865-870
• 4 Wang E E, Law B J, Boucher F D et al.. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection.  J Pediatr. 1996;  129 (3) 390-395
• 5 Duncan C B, Walsh E E, Peterson D R, Lee F E, Falsey A R. Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults.  J Infect Dis. 2009;  200 (8) 1242-1246
• 6 El Saleeby C M, Somes G W, DeVincenzo J P, Gaur A H. Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.  Pediatrics. 2008;  121 (2) 235-243
• 7 Hall C B, Powell K R, MacDonald N E et al.. Respiratory syncytial viral infection in children with compromised immune function.  N Engl J Med. 1986;  315 (2) 77-81
• 8 King Jr J C, Burke A R, Clemens J D et al.. Respiratory syncytial virus illnesses in human immunodeficiency virus- and noninfected children.  Pediatr Infect Dis J. 1993;  12 (9) 733-739
• 9 Milner M E, de la Monte S M, Hutchins G M. Fatal respiratory syncytial virus infection in severe combined immunodeficiency syndrome.  Am J Dis Child. 1985;  139 (11) 1111-1114
• 10 Chemaly R F, Ghosh S, Bodey G P et al.. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center.  Medicine (Baltimore). 2006;  85 (5) 278-287
• 11 Ljungman P, Ward K N, Crooks B N et al.. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.  Bone Marrow Transplant. 2001;  28 (5) 479-484
• 12 Nichols W G, Gooley T, Boeckh M. Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience.  Biol Blood Marrow Transplant. 2001;  7 (Suppl) 11S-15S
• 13 Whimbey E, Englund J A, Couch R B. Community respiratory virus infections in immunocompromised patients with cancer.  Am J Med. 1997;  102 (3A) 10-18 discussion 25-26
• 14 Ghosh S, Champlin R E, Englund J et al.. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.  Bone Marrow Transplant. 2000;  25 (7) 751-755
• 15 Martino R, Porras R P, Rabella N et al.. Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies.  Biol Blood Marrow Transplant. 2005;  11 (10) 781-796
• 16 Shah J N, Chemaly R F. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation.  Blood. 2011;  117 (10) 2755-2763
• 17 Chakinala M M, Walter M J. Community acquired respiratory viral infections after lung transplantation: clinical features and long-term consequences.  Semin Thorac Cardiovasc Surg. 2004;  16 (4) 342-349
• 18 Glanville A R, Scott A I, Morton J M et al.. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.  J Heart Lung Transplant. 2005;  24 (12) 2114-2119
• 19 Khalifah A P, Hachem R R, Chakinala M M et al.. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death.  Am J Respir Crit Care Med. 2004;  170 (2) 181-187
• 20 McCurdy L H, Milstone A, Dummer S. Clinical features and outcomes of paramyxoviral infection in lung transplant recipients treated with ribavirin.  J Heart Lung Transplant. 2003;  22 (7) 745-753
• 21 Milstone A P, Brumble L M, Barnes J et al.. A single-season prospective study of respiratory viral infections in lung transplant recipients.  Eur Respir J. 2006;  28 (1) 131-137
• 22 Palmer Jr S M, Henshaw N G, Howell D N, Miller S E, Davis R D, Tapson V F. Community respiratory viral infection in adult lung transplant recipients.  Chest. 1998;  113 (4) 944-950
• 23 Gottlieb J, Schulz T F, Welte T et al.. Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study.  Transplantation. 2009;  87 (10) 1530-1537
• 24 Miller R B, Chavers B M. Respiratory syncytial virus infections in pediatric renal transplant recipients.  Pediatr Nephrol. 1996;  10 (2) 213-215
• 25 Pohl C, Green M, Wald E R, Ledesma-Medina J. Respiratory syncytial virus infections in pediatric liver transplant recipients.  J Infect Dis. 1992;  165 (1) 166-169
• 26 Ison M G, Michaels M G. AST Infectious Diseases Community of Practice . RNA respiratory viral infections in solid organ transplant recipients.  Am J Transplant. 2009;  9 (Suppl 4) S166-S172
• 27 Hall C B, Douglas Jr R G. Modes of transmission of respiratory syncytial virus.  J Pediatr. 1981;  99 (1) 100-103
• 28 Hall C B, Douglas Jr R G, Schnabel K C, Geiman J M. Infectivity of respiratory syncytial virus by various routes of inoculation.  Infect Immun. 1981;  33 (3) 779-783
• 29 Hall C B, Douglas Jr R G, Geiman J M. Quantitative shedding patterns of respiratory syncytial virus in infants.  J Infect Dis. 1975;  132 (2) 151-156
• 30 Hall C B, Walsh E E, Schnabel K C et al.. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children.  J Infect Dis. 1990;  162 (6) 1283-1290
• 31 Jalal H, Bibby D F, Bennett J et al.. Molecular investigations of an outbreak of parainfluenza virus type 3 and respiratory syncytial virus infections in a hematology unit.  J Clin Microbiol. 2007;  45 (6) 1690-1696
• 32 Taylor G S, Vipond I B, Caul E O. Molecular epidemiology of outbreak of respiratory syncytial virus within bone marrow transplantation unit.  J Clin Microbiol. 2001;  39 (2) 801-803
• 33 Whimbey E, Champlin R E, Couch R B et al.. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients.  Clin Infect Dis. 1996;  22 (5) 778-782
• 34 Kassis C, Champlin R E, Hachem R Y et al.. Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab.  Biol Blood Marrow Transplant. 2010;  16 (9) 1265-1271
• 35 Machado A F, Sallum M A, Vilas Boas L S, Tateno A F, Machado C M. Molecular characterization of strains of respiratory syncytial virus identified in a hematopoietic stem cell transplant outpatient unit over 2 years: community or nosocomial infection?.  Biol Blood Marrow Transplant. 2008;  14 (12) 1348-1355
• 36 Avetisyan G, Mattsson J, Sparrelid E, Ljungman P. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.  Transplantation. 2009;  88 (10) 1222-1226
• 37 Hoffman S J, Laham F R, Polack F P. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response.  Microbes Infect. 2004;  6 (8) 767-772
• 38 Johnson J E, Gonzales R A, Olson S J, Wright P F, Graham B S. The histopathology of fatal untreated human respiratory syncytial virus infection.  Mod Pathol. 2007;  20 (1) 108-119
• 39 Everard M L, Swarbrick A, Wrightham M et al.. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection.  Arch Dis Child. 1994;  71 (5) 428-432
• 40 Nadal D, Wunderli W, Meurmann O, Briner J, Hirsig J. Isolation of respiratory syncytial virus from liver tissue and extrahepatic biliary atresia material.  Scand J Infect Dis. 1990;  22 (1) 91-93
• 41 Zlateva K T, Van Ranst M. Detection of subgroup B respiratory syncytial virus in the cerebrospinal fluid of a patient with respiratory syncytial virus pneumonia.  Pediatr Infect Dis J. 2004;  23 (11) 1065-1066
• 42 Garofalo R P, Hintz K H, Hill V, Patti J, Ogra P L, Welliver Sr R C. A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus.  J Med Virol. 2005;  75 (2) 282-289
• 43 Garofalo R P, Patti J, Hintz K A, Hill V, Ogra P L, Welliver R C. Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis.  J Infect Dis. 2001;  184 (4) 393-399
• 44 Jamaluddin M, Choudhary S, Wang S et al.. Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoter.  J Virol. 2005;  79 (24) 15302-15313
• 45 Legg J P, Hussain I R, Warner J A, Johnston S L, Warner J O. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis.  Am J Respir Crit Care Med. 2003;  168 (6) 633-639
• 46 Matsuda K, Tsutsumi H, Okamoto Y, Chiba C. Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus.  Clin Diagn Lab Immunol. 1995;  2 (3) 322-324
• 47 Smyth R L, Fletcher J N, Thomas H M, Hart C A. Immunological responses to respiratory syncytial virus infection in infancy.  Arch Dis Child. 1997;  76 (3) 210-214
• 48 Tripp R A, Moore D, Barskey IV A et al.. Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA.  J Infect Dis. 2002;  185 (10) 1388-1394
• 49 Welliver R C, Garofalo R P, Ogra P L. Beta-chemokines, but neither T helper type 1 nor T helper type 2 cytokines, correlate with severity of illness during respiratory syncytial virus infection.  Pediatr Infect Dis J. 2002;  21 (5) 457-461
• 50 Khanna N, Widmer A F, Decker M et al.. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.  Clin Infect Dis. 2008;  46 (3) 402-412
• 51 Schiffer J T, Kirby K, Sandmaier B, Storb R, Corey L, Boeckh M. Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation.  Haematologica. 2009;  94 (8) 1101-1108
• 52 Martino R, Piñana J L, Parody R et al.. Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT.  Bone Marrow Transplant. 2009;  44 (11) 749-756
• 53 Hall C B, Hall W J, Gala C L, MaGill F B, Leddy J P. Long-term prospective study in children after respiratory syncytial virus infection.  J Pediatr. 1984;  105 (3) 358-364
• 54 Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.  Am J Respir Crit Care Med. 2000;  161 (5) 1501-1507
• 55 Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Björkstén B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls.  Pediatrics. 1995;  95 (4) 500-505
• 56 Sigurs N, Gustafsson P M, Bjarnason R et al.. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.  Am J Respir Crit Care Med. 2005;  171 (2) 137-141
• 57 Stein R T, Sherrill D, Morgan W J et al.. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.  Lancet. 1999;  354 (9178) 541-545
• 58 Hall W J, Hall C B, Speers D M. Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies.  Ann Intern Med. 1978;  88 (2) 203-205
• 59 Erard V, Chien J W, Kim H W et al.. Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory viruses.  J Infect Dis. 2006;  193 (12) 1619-1625
• 60 Hopkins P, McNeil K, Kermeen F et al.. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus.  Am J Respir Crit Care Med. 2008;  178 (8) 876-881
• 61 Shah P D, McDyer J F. Viral infections in lung transplant recipients.  Semin Respir Crit Care Med. 2010;  31 (2) 243-254
• 62 Casiano-Colón A E, Hulbert B B, Mayer T K, Walsh E E, Falsey A R. Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults.  J Clin Virol. 2003;  28 (2) 169-174
• 63 Moore C, Valappil M, Corden S, Westmoreland D. Enhanced clinical utility of the NucliSens EasyQ RSV A + B Assay for rapid detection of respiratory syncytial virus in clinical samples.  Eur J Clin Microbiol Infect Dis. 2006;  25 (3) 167-174
• 64 Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.  Pediatrics. 1998;  102 (3 Pt 1) 531-537
• 65 Boeckh M, Englund J, Li Y NIAID Collaborative Antiviral Study Group et al. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients.  Clin Infect Dis. 2007;  44 (2) 245-249
• 66 Sparrelid E, Ljungman P, Ekelöf-Andström E et al.. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.  Bone Marrow Transplant. 1997;  19 (9) 905-908
• 67 Ghosh S, Champlin R E, Ueno N T et al.. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins.  Bone Marrow Transplant. 2001;  28 (3) 271-275
• 68 Markovic S N, Adlakha A, Smith T F, Walker R C. Respiratory syncytial virus pneumonitis-induced diffuse alveolar damage in an autologous bone marrow transplant recipient.  Mayo Clin Proc. 1998;  73 (2) 153-156
• 69 Small T N, Casson A, Malak S F et al.. Respiratory syncytial virus infection following hematopoietic stem cell transplantation.  Bone Marrow Transplant. 2002;  29 (4) 321-327
• 70 Boeckh M, Berrey M M, Bowden R A, Crawford S W, Balsley J, Corey L. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.  J Infect Dis. 2001;  184 (3) 350-354
• 71 Tsitsikas D A, Oakervee H, Cavenagh J D, Gribben J, Agrawal S G, Mattes F M. Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience.  Br J Haematol. 2009;  146 (5) 574-576
• 72 Lambert D M, Barney S, Lambert A L et al.. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion.  Proc Natl Acad Sci U S A. 1996;  93 (5) 2186-2191
• 73 Heilman C A. From the National Institute of Allergy and Infectious Diseases and the World Health Organization. Respiratory syncytial and parainfluenza viruses.  J Infect Dis. 1990;  161 (3) 402-406
• 74 Henderson F W. Pulmonary infections with respiratory syncytial virus and the parainfluenza viruses.  Semin Respir Infect. 1987;  2 (2) 112-121
• 75 Reed G, Jewett P H, Thompson J, Tollefson S, Wright P F. Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old.  J Infect Dis. 1997;  175 (4) 807-813
• 76 Hall C B. Respiratory syncytial virus and parainfluenza virus.  N Engl J Med. 2001;  344 (25) 1917-1928
• 77 Tyrrell D A, Bynoe M L, Petersen K B, Sutton R N, Pereira M S. Inoculation of human volunteers with parainfluenza viruses types 1 and 3 (HA 2 and HA 1).  BMJ. 1959;  2 (5157) 909-911
• 78 Avadhanula V, Rodriguez C A, Devincenzo J P et al.. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner.  J Virol. 2006;  80 (4) 1629-1636
• 79 Wendt C H, Weisdorf D J, Jordan M C, Balfour Jr H H, Hertz M I. Parainfluenza virus respiratory infection after bone marrow transplantation.  N Engl J Med. 1992;  326 (14) 921-926
• 80 Nichols W G, Corey L, Gooley T, Davis C, Boeckh M. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome.  Blood. 2001;  98 (3) 573-578
• 81 Elizaga J, Olavarria E, Apperley J, Goldman J, Ward K. Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment.  Clin Infect Dis. 2001;  32 (3) 413-418
• 82 Lewis V A, Champlin R, Englund J et al.. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients.  Clin Infect Dis. 1996;  23 (5) 1033-1037
• 83 Peck A J, Englund J A, Kuypers J et al.. Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infection.  Blood. 2007;  110 (5) 1681-1688
• 84 Hodson A, Kasliwal M, Streetly M, Macmahon E, Raj K. A parainfluenza-3 outbreak in a SCT unit: sepsis with multi-organ failure and multiple co-pathogens are associated with increased mortality.  Bone Marrow Transplant. 2011;  Jan 24. [Epub ahead of print]
• 85 Kuypers J, Campbell A P, Cent A, Corey L, Boeckh M. Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients.  Transpl Infect Dis. 2009;  11 (4) 298-303
• 86 Marx A, Gary Jr H E, Marston B J et al.. Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection.  Clin Infect Dis. 1999;  29 (1) 134-140
• 87 Hall C B. Hospital-acquired pneumonia in children: the role of respiratory viruses.  Semin Respir Infect. 1987;  2 (1) 48-56
• 88 Zambon M, Bull T, Sadler C J, Goldman J M, Ward K N. Molecular epidemiology of two consecutive outbreaks of parainfluenza 3 in a bone marrow transplant unit.  J Clin Microbiol. 1998;  36 (8) 2289-2293
• 89 Chakrabarti S, Avivi I, Mackinnon S et al.. Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality.  Br J Haematol. 2002;  119 (4) 1125-1132
• 90 Kumar D, Husain S, Chen M H et al.. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.  Transplantation. 2010;  89 (8) 1028-1033
• 91 Vilchez R A, McCurry K, Dauber J et al.. The epidemiology of parainfluenza virus infection in lung transplant recipients.  Clin Infect Dis. 2001;  33 (12) 2004-2008
• 92 Welliver R C, Wong D T, Middleton Jr E, Sun M, McCarthy N, Ogra P L. Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection.  J Pediatr. 1982;  101 (6) 889-896
• 93 Welliver R C, Wong D T, Sun M, McCarthy N. Parainfluenza virus bronchiolitis. Epidemiology and pathogenesis.  Am J Dis Child. 1986;  140 (1) 34-40
• 94 Porter D D, Prince G A, Hemming V G, Porter H G. Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rats: Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumonia.  J Virol. 1991;  65 (1) 103-111
• 95 Prince G A, Porter D D. Treatment of parainfluenza virus type 3 bronchiolitis and pneumonia in a cotton rat model using topical antibody and glucocorticosteroid.  J Infect Dis. 1996;  173 (3) 598-608
• 96 Ferguson P E, Sorrell T C, Bradstock K F, Carr P, Gilroy N M. Parainfluenza virus type 3 pneumonia in bone marrow transplant recipients: multiple small nodules in high-resolution lung computed tomography scans provide a radiological clue to diagnosis.  Clin Infect Dis. 2009;  Feb 17. [Epub ahead of print]
• 97 Vilchez R A, Dauber J, McCurry K, Iacono A, Kusne S. Parainfluenza virus infection in adult lung transplant recipients: an emergent clinical syndrome with implications on allograft function.  Am J Transplant. 2003;  3 (2) 116-120
• 98 Holt N D, Gould F K, Taylor C E et al.. Incidence and significance of noncytomegalovirus viral respiratory infection after adult lung transplantation.  J Heart Lung Transplant. 1997;  16 (4) 416-419
• 99 Wendt C H, Fox J M, Hertz M I. Paramyxovirus infection in lung transplant recipients.  J Heart Lung Transplant. 1995;  14 (3) 479-485
• 100 DeFabritus A M, Riggio R R, David D S, Senterfit L B, Cheigh J S, Stenzel K H. Parainfluenza type 3 in a transplant unit.  JAMA. 1979;  241 (4) 384-386
• 101 Herzog K D, Dunn S P, Langham Jr M R, Marmon L M. Association of parainfluenza virus type 3 infection with allograft rejection in a liver transplant recipient.  Pediatr Infect Dis J. 1989;  8 (8) 534-536
• 102 Laurichesse H, Dedman D, Watson J M, Zambon M C. Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975–1997.  Eur J Epidemiol. 1999;  15 (5) 475-484
• 103 Brady M T, Evans J, Cuartas J. Survival and disinfection of parainfluenza viruses on environmental surfaces.  Am J Infect Control. 1990;  18 (1) 18-23
• 104 Henrickson K J. Parainfluenza viruses.  Clin Microbiol Rev. 2003;  16 (2) 242-264
• 105 Stankova J, Carret A S, Moore D et al.. Long-term therapy with aerosolized ribavirin for parainfluenza 3 virus respiratory tract infection in an infant with severe combined immunodeficiency.  Pediatr Transplant. 2007;  11 (2) 209-213
• 106 Murrell M, Porotto M, Weber T, Greengard O, Moscona A. Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir).  J Virol. 2003;  77 (1) 309-317
• 107 Alymova I V, Taylor G, Takimoto T et al.. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo.  Antimicrob Agents Chemother. 2004;  48 (5) 1495-1502
• 108 Watanabe M, Mishin V P, Brown S A et al.. Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice.  Antimicrob Agents Chemother. 2009;  53 (9) 3942-3951
• 109 Ljungman P. Respiratory virus infections in bone marrow transplant recipients: the European perspective.  Am J Med. 1997;  102 (3A) 44-47
• 110 Bowden R A. Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience.  Am J Med. 1997;  102 (3A) 27-30 discussion 42-43
• 111 Nichols W G, Guthrie K A, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy.  Clin Infect Dis. 2004;  39 (9) 1300-1306
• 112 Vilchez R, McCurry K, Dauber J et al.. Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients.  Transplantation. 2002;  73 (7) 1075-1078
• 113 López-Medrano F, Aguado J M, Lizasoain M et al.. Clinical implications of respiratory virus infections in solid organ transplant recipients: a prospective study.  Transplantation. 2007;  84 (7) 851-856
• 114 Vilchez R A, McCurry K, Dauber J et al.. Influenza virus infection in adult solid organ transplant recipients.  Am J Transplant. 2002;  2 (3) 287-291
• 115 Maurer J R, Tullis D E, Grossman R F, Vellend H, Winton T L, Patterson G A. Infectious complications following isolated lung transplantation.  Chest. 1992;  101 (4) 1056-1059
• 116 Kramer M R, Marshall S E, Starnes V A, Gamberg P, Amitai Z, Theodore J. Infectious complications in heart-lung transplantation. Analysis of 200 episodes.  Arch Intern Med. 1993;  153 (17) 2010-2016
• 117 Ohori N P, Michaels M G, Jaffe R, Williams P, Yousem S A. Adenovirus pneumonia in lung transplant recipients.  Hum Pathol. 1995;  26 (10) 1073-1079
• 118 Billings J L, Hertz M I, Savik K, Wendt C H. Respiratory viruses and chronic rejection in lung transplant recipients.  J Heart Lung Transplant. 2002;  21 (5) 559-566
• 119 Weinberg A, Lyu D M, Li S, Marquesen J, Zamora M R. Incidence and morbidity of human metapneumovirus and other community-acquired respiratory viruses in lung transplant recipients.  Transpl Infect Dis. 2010;  12 (4) 330-335
• 120 Fox B D, Raviv Y, Rozengarten D, Rusanov V, Bakal I, Kramer M R. Pandemic influenza (H1N1): impact on lung transplant recipients and candidates.  J Heart Lung Transplant. 2010;  29 (9) 1034-1038
• 121 Choi S M, Boudreault A A, Xie H, Englund J A, Corey L, Boeckh M. Differences in clinical outcomes following 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients.  Blood. 2011;  117 (19) 5050-5056
• 122 Whimbey E, Elting L S, Couch R B et al.. Influenza A virus infections among hospitalized adult bone marrow transplant recipients.  Bone Marrow Transplant. 1994;  13 (4) 437-440
• 123 Malavaud S, Malavaud B, Sandres K et al.. Nosocomial outbreak of influenza virus A (H3N2) infection in a solid organ transplant department.  Transplantation. 2001;  72 (3) 535-537
• 124 Garbino J, Gerbase M W, Wunderli W et al.. Respiratory viruses and severe lower respiratory tract complications in hospitalized patients.  Chest. 2004;  125 (3) 1033-1039
• 125 Meylan P R, Aubert J D, Kaiser L. Influenza transmission to recipient through lung transplantation.  Transpl Infect Dis. 2007;  9 (1) 55-57
• 126 Le Page A K, Kainer G, Glanville A R, Tu E, Bhonagiri D, Rawlinson W D. Influenza B virus transmission in recipients of kidney and lung transplants from an infected donor.  Transplantation. 2010;  90 (1) 99-102
• 127 International Society of Heart and Lung Transplantation .Advisory statement on the implications of pandemic influenza for thoracic organ transplantation. 2009. http://www.ishlt.org/ContentDocuments/ISHLTInfluenzaPandemicRapidAdvisory.pdf Accessed May 15, 2009
• 128 OPTN/UNOS guidance regarding H1N1 and implications for transplantation. 2010. http://optn.transplant.hrsa.gov/news/newsDetail.asp?id=1292 Accessed January 7, 2010
• 129 Lee S H, Cheuh H, Yoo K H et al.. Hematopoietic stem cell transplantation from a related donor infected with influenza H1N1 2009.  Transpl Infect Dis. 2011;  Feb 23. doi: 10.1111/j.1399-3062.2011.00616.x. [Epub ahead of print]
• 130 Smith G J, Vijaykrishna D, Bahl J et al.. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic.  Nature. 2009;  459 (7250) 1122-1125
• 131 Garten R J, Davis C T, Russell C A et al.. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans.  Science. 2009;  325 (5937) 197-201
• 132 Dawood F S, Jain S, Finelli L Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans.  N Engl J Med. 2009;  360 (25) 2605-2615
• 133 van der Sluijs K F, van Elden L J, Nijhuis M et al.. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection.  J Immunol. 2004;  172 (12) 7603-7609
• 134 Sun K, Metzger D W. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection.  Nat Med. 2008;  14 (5) 558-564
• 135 Keane W R, Helderman J H, Luby J, Gailiunas P, Hull A R, Kokko J P. Epidemic renal transplant rejection associated with influenza A victoria.  Proc Clin Dial Transplant Forum. 1978;  8 232-236
• 136 Aschan J, Ringdén O, Ljungman P, Andersson J, Lewensohn-Fuchs I, Forsgren M. Influenza B in transplant patients.  Scand J Infect Dis. 1989;  21 (3) 349-350
• 137 Ljungman P, Andersson J, Aschan J et al.. Influenza A in immunocompromised patients.  Clin Infect Dis. 1993;  17 (2) 244-247
• 138 Mauch T J, Bratton S, Myers T, Krane E, Gentry S R, Kashtan C E. Influenza B virus infection in pediatric solid organ transplant recipients.  Pediatrics. 1994;  94 (2 Pt 1) 225-229
• 139 Khanna N, Steffen I, Studt J D et al.. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation.  Transpl Infect Dis. 2009;  11 (2) 100-105
• 140 Apalsch A M, Green M, Ledesma-Medina J, Nour B, Wald E R. Parainfluenza and influenza virus infections in pediatric organ transplant recipients.  Clin Infect Dis. 1995;  20 (2) 394-399
• 141 La Rosa A M, Malik S, Englund J A et al.. Influenza A in hospitalized adults with leukemia and hematopoietic stem cell transplant (HSCT) recipients; risk factors for progression to pneumonia. Paper presented at: 39th Annual Meeting of the Infectious Diseases Society of America; October 25–28, 2001; San Francisco, CA
• 142 Protheroe R E, Kirkland K E, Pearce R M et al.. The clinical features and outcome of 2009 H1N1 influenza infection in Allo-SCT patients: a British Society of Blood and Marrow Transplantation study.  Bone Marrow Transplant. 2011;  Feb 28. [Epub ahead of print]
• 143 Girmenia C, Mercanti C, Federico V et al.. Management of the 2009 A/H1N1 influenza pandemic in patients with hematologic diseases: a prospective experience at an Italian center.  Acta Haematol. 2011;  126 (1) 1-7
• 144 Rihani R, Hayajneh W, Sultan I et al.. Infections with the 2009 H1N1 influenza virus among hematopoietic SCT recipients: a single center experience.  Bone Marrow Transplant. 2011;  Jan 17. [Epub ahead of print]
• 145 Espinosa-Aguilar L, Green J S, Forrest G N et al.. Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experiences.  Biol Blood Marrow Transplant. 2011;  17 (4) 566-573
• 146 Low C Y, Kee T, Chan K P et al.. Pandemic (H1N1) 2009 infection in adult solid organ transplant recipients in Singapore.  Transplantation. 2010;  90 (9) 1016-1021
• 147 Kumar D, Erdman D, Keshavjee S et al.. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant.  Am J Transplant. 2005;  5 (8) 2031-2036
• 148 Faul J L, Akindipe O A, Berry G J, Theodore J. Influenza pneumonia in a paediatric lung transplant recipient.  Transpl Int. 2000;  13 (1) 79-81
• 149 Garantziotis S, Howell D N, McAdams H P, Davis R D, Henshaw N G, Palmer S M. Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome.  Chest. 2001;  119 (4) 1277-1280
• 150 Petric M, Comanor L, Petti C A. Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics.  J Infect Dis. 2006;  194 (Suppl 2) S98-S110
• 151 Weinberg A, Zamora M R, Li S, Torres F, Hodges T N. The value of polymerase chain reaction for the diagnosis of viral respiratory tract infections in lung transplant recipients.  J Clin Virol. 2002;  25 (2) 171-175
• 152 van Kraaij M G, van Elden L J, van Loon A M et al.. Frequent detection of respiratory viruses in adult recipients of stem cell transplants with the use of real-time polymerase chain reaction, compared with viral culture.  Clin Infect Dis. 2005;  40 (5) 662-669
• 153 Danzinger-Isakov L, Kumar D. AST Infectious Diseases Community of Practice . Guidelines for vaccination of solid organ transplant candidates and recipients.  Am J Transplant. 2009;  9 (Suppl 4) S258-S262
• 154 Ljungman P, Avetisyan G. Influenza vaccination in hematopoietic SCT recipients.  Bone Marrow Transplant. 2008;  42 (10) 637-641
• 155 Hayney M S, Moran J, Wiegert N A, Burlingham W J. Lung transplant patients' T cell responses to influenza vaccine viruses between seasons.  Vaccine. 2008;  26 (21) 2596-2600
• 156 Mazzone P J, Mossad S B, Mawhorter S D, Mehta A C, Schilz R J, Maurer J R. The humoral immune response to influenza vaccination in lung transplant patients.  Eur Respir J. 2001;  18 (6) 971-976
• 157 Fiore A E, Fry A, Shay D, Gubareva L, Bresee J S, Uyeki T M. Centers for Disease Control and Prevention (CDC) . Antiviral agents for the treatment and chemoprophylaxis of influenza—recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep. 2011;  60 (1) 1-24
• 158 Johny A A, Clark A, Price N, Carrington D, Oakhill A, Marks D I. The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation.  Bone Marrow Transplant. 2002;  29 (2) 113-115
• 159 Ison M G, Sharma A, Shepard J A, Wain J C, Ginns L C. Outcome of influenza infection managed with oseltamivir in lung transplant recipients.  J Heart Lung Transplant. 2008;  27 (3) 282-288
• 160 Kumar D, Morris M I, Kotton C N AST Infectious Diseases Community of Practice and Transplant Infectious Diseases Section of TTS et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients.  Am J Transplant. 2010;  10 (1) 18-25
• 161 Ison M G, Green M. AST Infectious Diseases Community of Practice . Adenovirus in solid organ transplant recipients.  Am J Transplant. 2009;  9 (Suppl 4) S161-S165
• 162 Barker J H, Luby J P, Sean Dalley A, Bartek W M, Burns D K, Erdman D D. Fatal type 3 adenoviral pneumonia in immunocompetent adult identical twins.  Clin Infect Dis. 2003;  37 (10) e142-e146
• 163 Dudding B A, Wagner S C, Zeller J A, Gmelich J T, French G R, Top Jr F H. Fatal pneumonia associated with adenovirus type 7 in three military trainees.  N Engl J Med. 1972;  286 (24) 1289-1292
• 164 Filho E P, da Costa Faria N R, Fialho A M et al.. Adenoviruses associated with acute gastroenteritis in hospitalized and community children up to 5 years old in Rio de Janeiro and Salvador, Brazil.  J Med Microbiol. 2007;  56 (Pt 3) 313-319
• 165 Madisch I, Wölfel R, Harste G, Pommer H, Heim A. Molecular identification of adenovirus sequences: a rapid scheme for early typing of human adenoviruses in diagnostic samples of immunocompetent and immunodeficient patients.  J Med Virol. 2006;  78 (9) 1210-1217
• 166 Hársi C M, Rolim D P, Gomes S A et al.. Adenovirus genome types isolated from stools of children with gastroenteritis in São Paulo, Brazil.  J Med Virol. 1995;  45 (2) 127-134
• 167 Fukuda S, Kuwayama M, Takao S, Shimazu Y, Miyazaki K. Molecular epidemiology of subgenus F adenoviruses associated with pediatric gastroenteritis during eight years in Hiroshima Prefecture as a limited area.  Arch Virol. 2006;  151 (12) 2511-2517
• 168 Sdiri-Loulizi K, Gharbi-Khelifi H, de Rougemont A et al.. Molecular epidemiology of human astrovirus and adenovirus serotypes 40/41 strains related to acute diarrhea in Tunisian children.  J Med Virol. 2009;  81 (11) 1895-1902
• 169 Magwalivha M, Wolfaardt M, Kiulia N M, van Zyl W B, Mwenda J M, Taylor M B. High prevalence of species D human adenoviruses in fecal specimens from urban Kenyan children with diarrhea.  J Med Virol. 2010;  82 (1) 77-84
• 170 Gonçalves G, Gouveia E, Mesquita J R et al.. Outbreak of acute gastroenteritis caused by adenovirus type 41 in a kindergarten.  Epidemiol Infect. 2010;  Dec 15:1–4. [Epub ahead of print]
• 171 Li L, Shimizu H, Doan L T et al.. Characterizations of adenovirus type 41 isolates from children with acute gastroenteritis in Japan, Vietnam, and Korea.  J Clin Microbiol. 2004;  42 (9) 4032-4039
• 172 Marie-Cardine A, Gourlain K, Mouterde O et al.. Epidemiology of acute viral gastroenteritis in children hospitalized in Rouen, France.  Clin Infect Dis. 2002;  34 (9) 1170-1178
• 173 Soares C C, Volotão E M, Albuquerque M C et al.. Prevalence of enteric adenoviruses among children with diarrhea in four Brazilian cities.  J Clin Virol. 2002;  23 (3) 171-177
• 174 Cunliffe N A, Booth J A, Elliot C et al.. Healthcare-associated viral gastroenteritis among children in a large pediatric hospital, United Kingdom.  Emerg Infect Dis. 2010;  16 (1) 55-62
• 175 Iturriza Gómara M, Simpson R, Perault A M et al.. Structured surveillance of infantile gastroenteritis in East Anglia, UK: incidence of infection with common viral gastroenteric pathogens.  Epidemiol Infect. 2008;  136 (1) 23-33
• 176 Zheng X, Lu X, Erdman D D et al.. Identification of adenoviruses in specimens from high-risk pediatric stem cell transplant recipients and controls.  J Clin Microbiol. 2008;  46 (1) 317-320
• 177 Ison M G. Adenovirus infections in transplant recipients.  Clin Infect Dis. 2006;  43 (3) 331-339
• 178 Buffington J, Chapman L E, Stobierski M G et al.. Epidemic keratoconjunctivitis in a chronic care facility: risk factors and measures for control.  J Am Geriatr Soc. 1993;  41 (11) 1177-1181
• 179 Singh-Naz N, Brown M, Ganeshananthan M. Nosocomial adenovirus infection: molecular epidemiology of an outbreak.  Pediatr Infect Dis J. 1993;  12 (11) 922-925
• 180 Koneru B, Atchison R, Jaffe R, Cassavilla A, Van Thiel D H, Starzl T E. Serological studies of adenoviral hepatitis following pediatric liver transplantation.  Transplant Proc. 1990;  22 (4) 1547-1548
• 181 Kojaoghlanian T, Flomenberg P, Horwitz M S. The impact of adenovirus infection on the immunocompromised host.  Rev Med Virol. 2003;  13 (3) 155-171
• 182 Garnett C T, Erdman D, Xu W, Gooding L R. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes.  J Virol. 2002;  76 (21) 10608-10616
• 183 Bil-Lula I, Ussowicz M, Rybka B et al.. Hematuria due to adenoviral infection in bone marrow transplant recipients.  Transplant Proc. 2010;  42 (9) 3729-3734
• 184 Echavarría M. Adenoviruses in immunocompromised hosts.  Clin Microbiol Rev. 2008;  21 (4) 704-715
• 185 Walls T, Shankar A G, Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients.  Lancet Infect Dis. 2003;  3 (2) 79-86
• 186 La Rosa A M, Champlin R E, Mirza N et al.. Adenovirus infections in adult recipients of blood and marrow transplants.  Clin Infect Dis. 2001;  32 (6) 871-876
• 187 Muller W J, Levin M J, Shin Y K et al.. Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients.  Clin Infect Dis. 2005;  41 (12) 1812-1816
• 188 Bordigoni P, Carret A S, Venard V, Witz F, Le Faou A. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation.  Clin Infect Dis. 2001;  32 (9) 1290-1297
• 189 de Mezerville M H, Tellier R, Richardson S, Hébert D, Doyle J, Allen U. Adenoviral infections in pediatric transplant recipients: a hospital-based study.  Pediatr Infect Dis J. 2006;  25 (9) 815-818
• 190 Sivaprakasam P, Carr T F, Coussons M et al.. Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention.  J Pediatr Hematol Oncol. 2007;  29 (2) 81-85
• 191 Neofytos D, Ojha A, Mookerjee B et al.. Treatment of adenovirus disease in stem cell transplant recipients with cidofovir.  Biol Blood Marrow Transplant. 2007;  13 (1) 74-81
• 192 Robin M, Marque-Juillet S, Scieux C et al.. Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome.  Haematologica. 2007;  92 (9) 1254-1257
• 193 Symeonidis N, Jakubowski A, Pierre-Louis S et al.. Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir.  Transpl Infect Dis. 2007;  9 (2) 108-113
• 194 Michaels M G, Green M, Wald E R, Starzl T E. Adenovirus infection in pediatric liver transplant recipients.  J Infect Dis. 1992;  165 (1) 170-174
• 195 Humar A, Kumar D, Mazzulli T PV16000 Study Group et al. A surveillance study of adenovirus infection in adult solid organ transplant recipients.  Am J Transplant. 2005;  5 (10) 2555-2559
• 196 McGrath D, Falagas M E, Freeman R et al.. Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance.  J Infect Dis. 1998;  177 (2) 459-462
• 197 Shirali G S, Ni J, Chinnock R E et al.. Association of viral genome with graft loss in children after cardiac transplantation.  N Engl J Med. 2001;  344 (20) 1498-1503
• 198 Yagisawa T, Nakada T, Takahashi K, Toma H, Ota K, Yaguchi H. Acute hemorrhagic cystitis caused by adenovirus after kidney transplantation.  Urol Int. 1995;  54 (3) 142-146
• 199 Yagisawa T, Takahashi K, Yamaguchi Y et al.. Adenovirus induced nephropathy in kidney transplant recipients.  Transplant Proc. 1989;  21 (1 Pt 2) 2097-2099
• 200 Humar A, Doucette K, Kumar D et al.. Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance.  J Heart Lung Transplant. 2006;  25 (12) 1441-1446
• 201 Bridges N D, Spray T L, Collins M H, Bowles N E, Towbin J A. Adenovirus infection in the lung results in graft failure after lung transplantation.  J Thorac Cardiovasc Surg. 1998;  116 (4) 617-623
• 202 Simsir A, Greenebaum E, Nuovo G, Schulman L L. Late fatal adenovirus pneumonitis in a lung transplant recipient.  Transplantation. 1998;  65 (4) 592-594
• 203 Lee J, Choi E H, Lee H J. Comprehensive serotyping and epidemiology of human adenovirus isolated from the respiratory tract of Korean children over 17 consecutive years (1991-2007).  J Med Virol. 2010;  82 (4) 624-631
• 204 Jones II M S, Harrach B, Ganac R D et al.. New adenovirus species found in a patient presenting with gastroenteritis.  J Virol. 2007;  81 (11) 5978-5984
• 205 Kajon A E, Lu X, Erdman D D et al.. Molecular epidemiology and brief history of emerging adenovirus 14-associated respiratory disease in the United States.  J Infect Dis. 2010;  202 (1) 93-103
• 206 Lu X, Erdman D D. Molecular typing of human adenoviruses by PCR and sequencing of a partial region of the hexon gene.  Arch Virol. 2006;  151 (8) 1587-1602
• 207 Houng H S, Gong H, Kajon A E et al.. Genome sequences of human adenovirus 14 isolates from mild respiratory cases and a fatal pneumonia, isolated during 2006-2007 epidemics in North America.  Respir Res. 2010;  11 116
• 208 Ebner K, Rauch M, Preuner S, Lion T. Typing of human adenoviruses in specimens from immunosuppressed patients by PCR-fragment length analysis and real-time quantitative PCR.  J Clin Microbiol. 2006;  44 (8) 2808-2815
• 209 Walls T, Hawrami K, Ushiro-Lumb I, Shingadia D, Saha V, Shankar A G. Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary?.  Clin Infect Dis. 2005;  40 (9) 1244-1249
• 210 Kajon A E, Dickson L M, Metzgar D, Houng H S, Lee V, Tan B H. Outbreak of febrile respiratory illness associated with adenovirus 11a infection in a Singapore military training cAMP.  J Clin Microbiol. 2010;  48 (4) 1438-1441
• 211 Chakrabarti S, Mautner V, Osman H et al.. Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery.  Blood. 2002;  100 (5) 1619-1627
• 212 Heemskerk B, Lankester A C, van Vreeswijk T et al.. Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients.  J Infect Dis. 2005;  191 (4) 520-530
• 213 van Tol M J, Claas E C, Heemskerk B et al.. Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity.  Bone Marrow Transplant. 2005;  35 (Suppl 1) S73-S76
• 214 Suparno C, Milligan D W, Moss P A, Mautner V. Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management.  Leuk Lymphoma. 2004;  45 (5) 873-885
• 215 Ahluwalia G S, Scott-Taylor T H, Klisko B, Hammond G W. Comparison of detection methods for adenovirus from enteric clinical specimens.  Diagn Microbiol Infect Dis. 1994;  18 (3) 161-166
• 216 Erard V, Huang M L, Ferrenberg J et al.. Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease.  Clin Infect Dis. 2007;  45 (8) 958-965
• 217 Lankester A C, Heemskerk B, Claas E C et al.. Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection.  Clin Infect Dis. 2004;  38 (11) 1521-1525
• 218 Yusuf U, Hale G A, Carr J et al.. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients.  Transplantation. 2006;  81 (10) 1398-1404
• 219 Leruez-Ville M, Minard V, Lacaille F et al.. Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection.  Clin Infect Dis. 2004;  38 (1) 45-52
• 220 Sujeet K, Vasudev B, Desai P et al.. Acute kidney injury requiring dialysis secondary to adenovirus nephritis in renal transplant recipient.  Transpl Infect Dis. 2011;  13 (2) 174-177
• 221 Jernigan J A, Lowry B S, Hayden F G et al.. Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control.  J Infect Dis. 1993;  167 (6) 1307-1313
• 222 Finn A, Anday E, Talbot G H. An epidemic of adenovirus 7a infection in a neonatal nursery: course, morbidity, and management.  Infect Control Hosp Epidemiol. 1988;  9 (9) 398-404
• 223 Morfin F, Dupuis-Girod S, Mundweiler S et al.. In vitro susceptibility of adenovirus to antiviral drugs is species-dependent.  Antivir Ther. 2005;  10 (2) 225-229
• 224 Rose K M, Leonard T B, Carter T H. Effects of adenine nucleosides on RNA synthesis in adenovirus-infected cells. 9-beta-D-Arabinofuranosyladenine as a selective inhibitor of RNA polyadenylation.  Mol Pharmacol. 1982;  22 (2) 517-523
• 225 Taylor D D, Jeffries D J, Taylor-Robinson D, Parkin J M, Tyms A S. The susceptibility of adenovirus infection to the anti-cytomegalovirus drug, ganciclovir (DHPG).  FEMS Microbiol Lett. 1988;  49 337-341
• 226 Ljungman P. Treatment of adenovirus infections in the immunocompromised host.  Eur J Clin Microbiol Infect Dis. 2004;  23 (8) 583-588
• 227 Naesens L, Lenaerts L, Andrei G et al.. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues.  Antimicrob Agents Chemother. 2005;  49 (3) 1010-1016
• 228 Gavin P J, Katz B Z. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children.  Pediatrics. 2002;  110 (1 Pt 1) e9
• 229 Hoffman J A, Shah A J, Ross L A, Kapoor N. Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation.  Biol Blood Marrow Transplant. 2001;  7 (7) 388-394
• 230 Ljungman P, Ribaud P, Eyrich M Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation et al. Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.  Bone Marrow Transplant. 2003;  31 (6) 481-486
• 231 Nagafuji K, Aoki K, Henzan H et al.. Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients.  Bone Marrow Transplant. 2004;  34 (10) 909-914
• 232 Fanourgiakis P, Georgala A, Vekemans M et al.. Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient.  Clin Infect Dis. 2005;  40 (1) 199-201
• 233 Keswani M, Moudgil A. Adenovirus-associated hemorrhagic cystitis in a pediatric renal transplant recipient.  Pediatr Transplant. 2007;  11 (5) 568-571
• 234 Doan M L, Mallory G B, Kaplan S L et al.. Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients.  J Heart Lung Transplant. 2007;  26 (9) 883-889
• 235 Feuchtinger T, Matthes-Martin S, Richard C et al.. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation.  Br J Haematol. 2006;  134 (1) 64-76
• 236 Leen A M, Myers G D, Sili U et al.. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.  Nat Med. 2006;  12 (10) 1160-1166
• 237 van den Hoogen B G, de Jong J C, Groen J et al.. A newly discovered human pneumovirus isolated from young children with respiratory tract disease.  Nat Med. 2001;  7 (6) 719-724
• 238 Kahn J S. Epidemiology of human metapneumovirus.  Clin Microbiol Rev. 2006;  19 (3) 546-557
• 239 Oliveira R, Machado A, Tateno A, Boas L V, Pannuti C, Machado C. Frequency of human metapneumovirus infection in hematopoietic SCT recipients during 3 consecutive years.  Bone Marrow Transplant. 2008;  42 (4) 265-269
• 240 Greensill J, McNamara P S, Dove W, Flanagan B, Smyth R L, Hart C A. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis.  Emerg Infect Dis. 2003;  9 (3) 372-375
• 241 Kamboj M, Gerbin M, Huang C-K et al.. Clinical characterization of human metapneumovirus infection among patients with cancer.  J Infect. 2008;  57 (6) 464-471
• 242 Garbino J, Soccal P M, Aubert J D et al.. Respiratory viruses in bronchoalveolar lavage: a hospital-based cohort study in adults.  Thorax. 2009;  64 (5) 399-404
• 243 Sumino K C, Agapov E, Pierce R A et al.. Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment.  J Infect Dis. 2005;  192 (6) 1052-1060
• 244 Larcher C, Geltner C, Fischer H, Nachbaur D, Müller L C, Huemer H P. Human metapneumovirus infection in lung transplant recipients: clinical presentation and epidemiology.  J Heart Lung Transplant. 2005;  24 (11) 1891-1901
• 245 Gerna G, Vitulo P, Rovida F et al.. Impact of human metapneumovirus and human cytomegalovirus versus other respiratory viruses on the lower respiratory tract infections of lung transplant recipients.  J Med Virol. 2006;  78 (3) 408-416
• 246 Debur M C, Vidal L R, Stroparo E et al.. Human metapneumovirus infection in hematopoietic stem cell transplant recipients.  Transpl Infect Dis. 2010;  12 (2) 173-179
• 247 Schildgen O, Glatzel T, Geikowski T et al.. Human metapneumovirus RNA in encephalitis patient.  Emerg Infect Dis. 2005;  11 (3) 467-470
• 248 Campbell A P, Chien J W, Kuypers J et al.. Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCT.  J Infect Dis. 2010;  201 (9) 1404-1413
• 249 Don M, Korppi M. Serologically defined human metapneumovirus in pediatric community-acquired pneumonia.  J Pediatr. 2011;  158 (1) 173
• 250 Wyde P R, Chetty S N, Jewell A M, Boivin G, Piedra P A. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro.  Antiviral Res. 2003;  60 (1) 51-59
• 251 Safdar A. Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients.  Bone Marrow Transplant. 2008;  41 (8) 707-708
• 252 Abdul-Rasool S, Fielding B C. Understanding human coronavirus HCoV-NL63.  Open Virol J. 2010;  4 76-84
• 253 Tyrrell D A, Bynoe M L. Cultivation of a novel type of common-cold virus in organ cultures.  BMJ. 1965;  1 (5448) 1467-1470
• 254 Hamre D, Procknow J J. A new virus isolated from the human respiratory tract.  Proc Soc Exp Biol Med. 1966;  121 (1) 190-193
• 255 Woo P CY, Lau S KP, Chu C M et al.. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia.  J Virol. 2005;  79 (2) 884-895
• 256 van der Hoek L, Pyrc K, Jebbink M F van der H et al. Identification of a new human coronavirus.  Nat Med. 2004;  10 (4) 368-373
• 257 Pyrc K, Jebbink M F, Berkhout B, van der Hoek L. Genome structure and transcriptional regulation of human coronavirus NL63.  Virol J. 2004;  1 7
• 258 Milano F, Campbell A P, Guthrie K A et al.. Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients.  Blood. 2010;  115 (10) 2088-2094
• 259 Garbino J, Crespo S, Aubert J D et al.. A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection.  Clin Infect Dis. 2006;  43 (8) 1009-1015
• 260 Folz R J, Elkordy M A. Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer.  Chest. 1999;  115 (3) 901-905
• 261 Oosterhof L, Christensen C B, Sengeløv H. Fatal lower respiratory tract disease with human corona virus NL63 in an adult haematopoietic cell transplant recipient.  Bone Marrow Transplant. 2010;  45 (6) 1115-1116
• 262 Arruda E, Pitkäranta A, Witek Jr T J, Doyle C A, Hayden F G. Frequency and natural history of rhinovirus infections in adults during autumn.  J Clin Microbiol. 1997;  35 (11) 2864-2868
• 263 Liu M, Worley S, Arrigain S et al.. Respiratory viral infections within one year after pediatric lung transplant.  Transpl Infect Dis. 2009;  11 (4) 304-312
• 264 Garbino J, Gerbase M W, Wunderli W et al.. Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact.  Am J Respir Crit Care Med. 2004;  170 (11) 1197-1203
• 265 Hassan I A, Chopra R, Swindell R, Mutton K J. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience.  Bone Marrow Transplant. 2003;  32 (1) 73-77
• 266 Gutman J A, Peck A J, Kuypers J, Boeckh M. Rhinovirus as a cause of fatal lower respiratory tract infection in adult stem cell transplantation patients: a report of two cases.  Bone Marrow Transplant. 2007;  40 (8) 809-811
• 267 Liu M, Mallory G B, Schecter M G et al.. Long-term impact of respiratory viral infection after pediatric lung transplantation.  Pediatr Transplant. 2010;  14 (3) 431-436
• 268 Crooks B N, Taylor C E, Turner A J et al.. Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit.  Bone Marrow Transplant. 2000;  26 (10) 1097-1102
• 269 Costa C, Bergallo M, Cavallo R. Detection of human bocavirus in bronchoalveolar lavage from Italian adult patients.  J Clin Virol. 2009;  45 (1) 81-82
• 270 Parody R, Rabella N, Martino R et al.. Upper and lower respiratory tract infections by human enterovirus and rhinovirus in adult patients with hematological malignancies.  Am J Hematol. 2007;  82 (9) 807-811
• 271 Kaiser L, Aubert J-D, Pache J-C et al.. Chronic rhinoviral infection in lung transplant recipients.  Am J Respir Crit Care Med. 2006;  174 (12) 1392-1399
• 272 Gerna G, Piralla A, Rovida F et al.. Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients.  J Med Virol. 2009;  81 (8) 1498-1507
• 273 Costa C, Bergallo M, Sidoti F et al.. What role for human rhinoviruses in the lower respiratory tract?.  New Microbiol. 2009;  32 (1) 115-117
• 274 Jefferson T O, Tyrrell D. Antivirals for the common cold.  Cochrane Database Syst Rev. 2001;  (3) CD002743
• 275 Allander T, Tammi M T, Eriksson M, Bjerkner A, Tiveljung-Lindell A, Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples.  Proc Natl Acad Sci U S A. 2005;  102 (36) 12891-12896
• 276 Maggi F, Andreoli E, Pifferi M, Meschi S, Rocchi J, Bendinelli M. Human bocavirus in Italian patients with respiratory diseases.  J Clin Virol. 2007;  38 (4) 321-325
• 277 Heegaard E D, Brown K E. Human parvovirus B19.  Clin Microbiol Rev. 2002;  15 (3) 485-505
• 278 Vicente D, Cilla G, Montes M, Pérez-Yarza E G, Pérez-Trallero E. Human bocavirus, a respiratory and enteric virus.  Emerg Infect Dis. 2007;  13 (4) 636-637
• 279 Schenk T, Strahm B, Kontny U, Hufnagel M, Neumann-Haefelin D, Falcone V. Disseminated bocavirus infection after stem cell transplant.  Emerg Infect Dis. 2007;  13 (9) 1425-1427
• 280 Lau S KP, Yip C CY, Que T-L et al.. Clinical and molecular epidemiology of human bocavirus in respiratory and fecal samples from children in Hong Kong.  J Infect Dis. 2007;  196 (7) 986-993
• 281 Miyakis S, van Hal S J, Barratt J, Stark D, Marriott D, Harkness J. Absence of human bocavirus in bronchoalveolar lavage fluid of lung transplant patients.  J Clin Virol. 2009;  44 (2) 179-180
• 282 Christensen A, Nordbø S A, Krokstad S, Rognlien A G, Døllner H. Human bocavirus in children: mono-detection, high viral load and viraemia are associated with respiratory tract infection.  J Clin Virol. 2010;  49 (3) 158-162
• 283 Williams J V. Déjà vu all over again: Koch's postulates and virology in the 21st century.  J Infect Dis. 2010;  201 (11) 1611-1614
• 284 Manteufel J, Truyen U. Animal bocaviruses: a brief review.  Intervirology. 2008;  51 (5) 328-334
• 285 Don M, Söderlund-Venermo M, Hedman K, Ruuskanen O, Allander T, Korppi M. Don't forget serum in the diagnosis of human bocavirus infection.  J Infect Dis. 2011;  203 (7) 1031-1032 author reply 1032-1033
• 286 Burton C M, Carlsen J, Mortensen J, Andersen C B, Milman N, Iversen M. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome.  J Heart Lung Transplant. 2007;  26 (7) 681-686
• 287 Welsh R M, Markees T G, Woda B A et al.. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody.  J Virol. 2000;  74 (5) 2210-2218
• 288 Winter J B, Gouw A S, Groen M, Wildevuur C, Prop J. Respiratory viral infections aggravate airway damage caused by chronic rejection in rat lung allografts.  Transplantation. 1994;  57 (3) 418-422
• 289 Kuo E, Bharat A, Goers T et al.. Respiratory viral infection in obliterative airway disease after orthotopic tracheal transplantation.  Ann Thorac Surg. 2006;  82 (3) 1043-1050